Related Experiment Video
Updated: Jul 1, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
S100A8/A9-High Macrophages Activate Intestinal Fibroblasts via mCCL6/hCCL15-CCR1 Axis to Drive Intestinal Fibrosis in
Shu Wang1, Jiayun Wang1, Junjie Lin1
1Department of Gastroenterology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Abstract:
Intestinal fibrosis presents a major clinical challenge in Crohn's disease (CD) due to the lack of effective pharmacological interventions. The underlying mechanisms of intestinal fibrosis remain largely elusive. Reanalysis of the single-cell RNA-seq data from full-thickness CD tissue identifies a distinct profibrotic macrophage subset characterized by high S100A8 and S100A9 expression. CellChat analysis indicates strong communication between this S100A8/A9-high (S100A8/A9hi) macrophage subset and fibroblasts. Adoptive transfer of S100A8/A9hi macrophages exacerbate intestinal fibrosis in mice with chronic dextran sulfate sodium (DSS)-induced colitis. Consequently, pharmacological inhibition of S100A8/A9 significantly ameliorates intestinal fibrosis in murine chronic colitis. Proteomic analysis further identifies murine CCL6 (mCCL6) as the key pro-fibrotic mediator secreted by S100A8/A9hi macrophages, which acts via CC chemokine receptor 1 (CCR1) to regulate fibroblasts. Antibody blockade of mCCL6 alleviates established intestinal fibrosis in a DSS-induced colitis model. Mechanistically, S100A8/A9hi macrophages drive mCCL6 production via STAT3 activation. Similarly, the human ortholog of CCL6, CCL15 (hCCL15), exerts pro-fibrotic effects on fibroblasts via the CCR1 receptor. Our findings reveal that targeting S100A8/A9hi macrophage may be a therapeutic strategy against intestinal fibrosis in CD.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Inflammation: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

